Check out

Monday, September 22, 2025

The Company Behind Tylenol Tries to Navigate Its Latest Crisis

Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism.

from NYT > Health https://ift.tt/8t59VsX

No comments:

Post a Comment

$2.5 Million Rift Pits Cannabis Pioneer Against Group That Backed Her

A dispute between the nonprofit Housing Works and the owner of a cannabis dispensary shows the risks for businesses in an industry that is l...